Paper9968
Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.
Richards DA and 2 others. Br J Clin Pharmacol, 1976. Cited by 106 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol. Papers, record 9968. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9968
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic alpha-Antagonists | Major topic |
| Adrenergic beta-Antagonists | Major topic |
| Ethanolamines | Major topic |
| Labetalol | Major topic |
| Adult | |
| Blood Pressure | |
| Dose-Response Relationship, Drug | |
| Heart Rate | |
| Humans | |
| Isoproterenol | |
| Male | |
| Phenylephrine |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 13,887,414 | Clinical pharmacology of a beta-adrenergic-blocking agent (Nethalide). | Lancet | 1962 | https://conductscience.org/library/papers/13887414 | PubMed |
| 2 | 13,889,121 | Circulatory effects of sympathomimetic amines. | Am Heart J | 1962 | https://conductscience.org/library/papers/13889121 | PubMed |
| 3 | 14,089,056 | A SPHYGMOMANOMETER FOR EPIDEMIOLOGISTS. | Lancet | 1964 | https://conductscience.org/library/papers/14089056 | PubMed |
| 4 | 186,090 | Beta-adrenoceptors in the human dorsal hand vein, and the effects of propranolol and practolol on venous sensitivity to noradrenaline. | Br J Clin Pharmacol | 1975 | https://conductscience.org/library/papers/186090 | PubMed |
| 5 | 238,705 | Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals. | Br J Pharmacol | 1975 | https://conductscience.org/library/papers/238705 | PubMed |
| 6 | 242,209 | Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. | Am J Cardiol | 1975 | https://conductscience.org/library/papers/242209 | PubMed |
| 7 | 4,148,916 | Clinical investigation of an antagonist at alpha- and beta-adrenoceptors-AH5158A. | Br J Pharmacol | 1972 | https://conductscience.org/library/papers/4148916 | PubMed |
| 8 | 4,362,588 | Adrenoceptors and adenyl cyclase in gills. | Br J Pharmacol | 1973 | https://conductscience.org/library/papers/4362588 | PubMed |
| 9 | 4,396,864 | Preliminary studies of the pharmacological effects of 5-[1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)-ethyl] salicylamide (AH 5158) in man. | Clin Sci | 1971 | https://conductscience.org/library/papers/4396864 | PubMed |
| 10 | 4,404,413 | Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors. | Br J Pharmacol | 1972 | https://conductscience.org/library/papers/4404413 | PubMed |
| 11 | 4,850,484 | Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension. | Br Heart J | 1974 | https://conductscience.org/library/papers/4850484 | PubMed |
| 12 | 4,877,600 | Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise. | Br J Pharmacol | 1968 | https://conductscience.org/library/papers/4877600 | PubMed |
| 13 | 802,650 | Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension. | Clin Sci Mol Med Suppl | 1975 | https://conductscience.org/library/papers/802650 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,973,651 | Labetalol Dosing in Pregnancy: PBPK/PD and CYP2C19 Polymorphisms. | J Clin Pharmacol | 2024 | https://conductscience.org/library/papers/38973651 | PubMed |
| 32,709,242 | Retrospective evaluation of labetalol as antihypertensive agent in dogs. | BMC Vet Res | 2020 | https://conductscience.org/library/papers/32709242 | PubMed |
| 28,520,538 | Treatment Strategies for Paradoxical Hypertension Following Surgical Correction of Coarctation of the Aorta in Children. | World J Pediatr Congenit Heart Surg | 2017 | https://conductscience.org/library/papers/28520538 | PubMed |
| 28,515,115 | Impact of Antihypertensive Treatment on Maternal and Perinatal Outcomes in Pregnancy Complicated by Chronic Hypertension: A Systematic Review and Meta-Analysis. | J Am Heart Assoc | 2017 | https://conductscience.org/library/papers/28515115 | PubMed |
| 8,723,167 | Tilisolol hydrochloride dilates coronary arteries through an ATP-sensitive K(+)-channel opening mechanism in dogs. | Cardiovasc Drugs Ther | 1996 | https://conductscience.org/library/papers/8723167 | PubMed |
| 7,371,699 | Acute and long-term effects of labetalol on systemic and pulmonary haemodynamics in hypertensive patients. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7371699 | PubMed |
| 7,093,103 | Elimination kinetics of labetalol in severe renal failure. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7093103 | PubMed |
| 7,093,094 | Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7093094 | PubMed |
| 6,849,742 | Changes in heart rate and forearm blood flow following intravenous boluses of isoprenaline in the presence of practolol and propranolol. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6849742 | PubMed |
| 6,310,204 | Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension. | Klin Wochenschr | 1983 | https://conductscience.org/library/papers/6310204 | PubMed |
| 6,151,889 | Pharmacology of combined alpha-beta-blockade. I. | Drugs | 1984 | https://conductscience.org/library/papers/6151889 | PubMed |
| 6,145,440 | Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6145440 | PubMed |
| 6,143,666 | Propranolol vs metoprolol vs labetalol: a comparative study in essential hypertension. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6143666 | PubMed |
| 6,122,340 | Improved deep controlled hypotension in aneurysmal surgery. | Acta Neurochir (Wien) | 1982 | https://conductscience.org/library/papers/6122340 | PubMed |
| 3,714,619 | Management of ventricular arrhythmias associated with mitral valve prolapse by combined alpha and beta blockade. | Postgrad Med J | 1986 | https://conductscience.org/library/papers/3714619 | PubMed |
| 2,908,732 | Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia. | Cardiovasc Drugs Ther | 1988 | https://conductscience.org/library/papers/2908732 | PubMed |
| 861,131 | Effects of labetalol and propranolol on histamine-induced bronchoconstriction in normal subjects. | Br J Clin Pharmacol | 1977 | https://conductscience.org/library/papers/861131 | PubMed |
| 843,418 | Comparison of the effects of labetalol and propranolol in healthy men at rest and during exercise. | Br J Clin Pharmacol | 1977 | https://conductscience.org/library/papers/843418 | PubMed |
| 526,410 | Effect of labetalol in hypertension during exercise and postural changes. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/526410 | PubMed |
| 385,023 | A comparison of the effects of labetalol, bendrofluazide and their combination in hypertension. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/385023 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9968
GET https://conductscience.org/api/papers/v1/9968/cited_by?page=2